A sharp 1% drop in May producer prices weighed the markets down to a lower open with the Dow slipping 24 points to 12,549. Nasdaq lost 5 points to 2837.
On the upside
Summer Street Research initiated coverage of Dendreon (Nasdaq: DNDN) with a Buy rating.
Dell (Nasdaq: DELL) announced its first ever quarterly dividend of 8 cents per share to be paid in the third quarter.
Shares of Arena Pharmaceuticals (Nasdaq: ARNA) continued climbing in anticipation of regulatory approval of its obesity treatment Lorcaserin by June 27.
On the downside
Wunderlich Securities analyst Theordore O'Neill questioned whether A123 Systems's (Nasdaq: AONE) new extreme weather lithium ion technology would generate enough revenue to keep the battery maker solvent.
Endeavour International (NYSE: END) priced its public offering of 7.5 million common shares at the discounted price of $7.50 per share.
Shares of Regeneron (Nasdaq: REGN) fell after Ophthotech reported upbeat results from a clinical trial of its wet age-related macular degeneration treatment Fovista which will compete with Regeneron's Eylea.
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 2 on both the NYSE and on Nasdaq. The Russell 2000 which tracks small cap stocks fell 4 points to 756.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here